As we usher in 2025, it’s the perfect time to prioritize health and wellness. Recently, Registered Dietitian & Nutritionist Kelly Bristow from Bayer, one of the country's largest life-sciences ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth quarter 2024 investor letter. A ...

Health news updates include the EU contemplating curbs on Chinese medical device makers, Pfizer reducing its stake in Haleon, toothpaste lawsuits over fluoride, Eli Lilly’s stock drop, biopharma ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Kerenida is currently approved to slow the progression chronic kidney disease associated with type 2 diabetes.

Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary of global life sciences titan Bayer AG. Financial terms of the deal with ...

Health-care providers and insurance companies can play a key role in educating, empowering, and supporting women in their ...

A new trend is emerging among corporations to seek immunity from prosecution and prevent consumers from suing after the ...